Mannkind (MNKD) Asset Writedowns and Impairment (2017 - 2026)

Mannkind (MNKD) reported Asset Writedowns and Impairment of $1.1 million for Q1 2026, up 130.69% year-over-year from $466000.0 in Q1 2025, and down 48.74% quarter-over-quarter from $2.1 million in Q4 2025.

Mannkind (MNKD) Asset Writedowns and Impairment (2017 - 2026) Analysis & Trends

Mannkind (MNKD) has 9 years of Asset Writedowns and Impairment data on file, last reported at $1.1 million in Q1 2026.

  • Asset Writedowns and Impairment for Q1 2026 came in at $1.1 million, up 130.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.1 million (up 234.3% YoY), and the FY2025 annual result was $10.4 million, up 169.7% from the prior year.
  • Asset Writedowns and Impairment retreated to $1.1 million in Q1 2026 per MNKD's latest filing, from $2.1 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $4.6 million in Q2 2025 and troughed at $300000.0 in Q3 2023.
  • A 5-year average of $1.4 million and a median of $950000.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
  • The sharpest annual moves came in 2023 and 2025: Asset Writedowns and Impairment sank 66.67% in 2023, then soared 1000.0% in 2025.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $834000.0 in 2022, then increased by 4.8% to $874000.0 in 2023, then soared by 122.65% to $1.9 million in 2024, then increased by 7.76% to $2.1 million in 2025, then slumped by 48.74% to $1.1 million in 2026.
  • Business Quant data shows MNKD's Asset Writedowns and Impairment at $1.1 million in Q1 2026, $2.1 million in Q4 2025, and $3.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Mannkind 1.21 Bn 1.08 Bn 82.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.08 Mn
Mar 31, 2026 1.08 Mn
Dec 31, 2025 2.10 Mn
Dec 31, 2025 2.10 Mn
Sep 30, 2025 3.30 Mn
Sep 30, 2025 3.30 Mn
Jun 30, 2025 4.60 Mn
Jun 30, 2025 4.60 Mn
Mar 31, 2025 466,000.00
Mar 31, 2025 466,000.00
Dec 31, 2024 1.95 Mn
Dec 31, 2024 1.95 Mn
Sep 30, 2024 300,000.00
Sep 30, 2024 300,000.00
Jun 30, 2024 600,000.00
Jun 30, 2024 600,000.00
Mar 31, 2024 1.03 Mn
Mar 31, 2024 1.03 Mn
Dec 31, 2023 874,000.00
Dec 31, 2023 874,000.00